DLDRX | TRNEX | DLDRX / TRNEX | |
Total Expense Ratio | 0.89 | 0.57 | 156% |
Annual Report Gross Expense Ratio | 0.75 | 0.57 | 132% |
Fund Existence | 22 years | 9 years | - |
Gain YTD | -5.783 | 2.964 | -195% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 500000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.06B | 2.3B | 46% |
Annual Yield % from dividends | 1.51 | 2.27 | 67% |
Returns for 1 year | -19.64 | -3.63 | 542% |
Returns for 3 years | -32.05 | -5.37 | 596% |
Returns for 5 years | 70.29 | 53.70 | 131% |
Returns for 10 years | 44.58 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
QASGX | 25.25 | 0.39 | +1.57% |
Federated Hermes MDT Small Cap Growth A | |||
JFNSX | 61.87 | 0.21 | +0.34% |
Janus Henderson Global Life Sciences S | |||
TMCAX | 11.53 | N/A | N/A |
RBC SMID Cap Growth A | |||
JEMZX | 9.51 | N/A | N/A |
JHancock Emerging Markets Equity C | |||
EEMHX | 8.60 | N/A | N/A |
MFS Emerging Markets Equity Research R6 |